USANA HEALTH SCIENCES INC's ticker is USNA and the CUSIP is 90328M107. A total of 195 filers reported holding USANA HEALTH SCIENCES INC in Q3 2020. The put-call ratio across all filers is 0.46 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $600 | -11.1% | 10,241 | -4.4% | 0.00% | -50.0% |
Q2 2023 | $675 | -2.7% | 10,707 | -3.0% | 0.00% | 0.0% |
Q1 2023 | $694 | +14.1% | 11,039 | -3.4% | 0.00% | 0.0% |
Q4 2022 | $608 | -99.9% | 11,426 | -0.7% | 0.00% | 0.0% |
Q3 2022 | $645,000 | -21.1% | 11,510 | +1.8% | 0.00% | 0.0% |
Q2 2022 | $818,000 | +8.3% | 11,311 | +19.0% | 0.00% | +100.0% |
Q1 2022 | $755,000 | -21.5% | 9,506 | +0.0% | 0.00% | -50.0% |
Q4 2021 | $962,000 | +7.5% | 9,503 | -2.1% | 0.00% | 0.0% |
Q3 2021 | $895,000 | -7.3% | 9,706 | +2.9% | 0.00% | 0.0% |
Q2 2021 | $966,000 | +1.4% | 9,430 | -3.4% | 0.00% | 0.0% |
Q1 2021 | $953,000 | +24.4% | 9,764 | -1.7% | 0.00% | 0.0% |
Q4 2020 | $766,000 | +4.8% | 9,932 | 0.0% | 0.00% | 0.0% |
Q3 2020 | $731,000 | -2.4% | 9,932 | -2.6% | 0.00% | 0.0% |
Q2 2020 | $749,000 | +23.2% | 10,202 | -3.0% | 0.00% | 0.0% |
Q1 2020 | $608,000 | -22.5% | 10,520 | +5.3% | 0.00% | 0.0% |
Q4 2019 | $785,000 | +12.0% | 9,995 | -2.6% | 0.00% | 0.0% |
Q3 2019 | $701,000 | -15.1% | 10,257 | -1.4% | 0.00% | -33.3% |
Q2 2019 | $826,000 | – | 10,399 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DENALI ADVISORS LLC | 50,729 | $3,190,854 | 1.33% |
Cypress Capital, LLC | 12,227 | $769,078 | 0.25% |
DGS Capital Management, LLC | 6,835 | $429,922 | 0.24% |
PZENA INVESTMENT MANAGEMENT LLC | 818,384 | $51,476,354 | 0.22% |
WINTON GROUP Ltd | 26,950 | $1,695,155 | 0.10% |
Renaissance Technologies | 1,211,797 | $76,222 | 0.10% |
Covestor Ltd | 1,602 | $101 | 0.09% |
ACADIAN ASSET MANAGEMENT LLC | 267,057 | $16,778 | 0.07% |
Ifrah Financial Services, Inc. | 3,368 | $211,847 | 0.07% |
CAXTON ASSOCIATES LP | 5,928 | $372,871 | 0.06% |